Christoph B Olivier

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Percutaneous Coronary Intervention

Antiplatelet Therapy

Atrial Fibrillation

Top Venues

Journal of thrombosis and thrombolysis

Journal of clinical medicine

Expert opinion on drug safety

The journal of vascular access

This page only lists publications with an associated author ORCID identifier.

Publications

Diona Gjermeni, Hannah Vetter, Sofia Szabó, Viktoria Anfang, Stefan Leggewie, David Hesselbarth, Daniel Duerschmied, Dietmar Trenk, Christoph B Olivier
Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Journal of clinical medicine 11 (14) (2022)
David Hesselbarth, Diona Gjermeni, Sofia Szabo, Patrick M Siegel, Philipp Diehl, Martin Moser, Christoph Bode, Christoph B Olivier
Time from blood draw to multiple electrode aggregometry and association with platelet reactivity. Journal of thrombosis and thrombolysis (2022)
Christoph B Olivier, Vandana Sundaram, Glenn M Chertow, Sumana Shashidhar, Lori K McDonnell, Victoria Y Ding, Manisha Desai, Kenneth W Mahaffey, Matthew Mell
A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation. The journal of vascular access 21 (4) (2019)
Christoph B Olivier, Mintu P Turakhia, Kenneth W Mahaffey
Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome. Expert opinion on drug safety 17 (3) (2018)
Jonathan Rilinger, Melanie Meyer, Katharina Schnabel, Patrick Weik, Anne Charlet, Jennifer S Esser, Qian Zhou, Christoph Bode, Martin Moser, Philipp Diehl, Christoph B Olivier
High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting. Journal of thrombosis and thrombolysis 42 (4) (2017)
Christoph B Olivier, Patrick Weik, Melanie Meyer, Susanne Weber, Philipp Diehl, Christoph Bode, Martin Moser, Qian Zhou
Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors. Journal of thrombosis and thrombolysis 42 (2) (2017)
Christoph B Olivier, Katharina Schnabel, Susanne Weber, Qian Zhou, Christoph Bode, Martin Moser, Philipp Diehl
Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrel. Journal of thrombosis and thrombolysis 42 (1) (2017)